A U.S. federal judge has sided with a U.S. regulator's decision last year to take Eli Lilly’s blockbuster weight loss and ...

Eli Lilly misses first-quarter estimates for earnings but beats the same for sales. Mounjaro and Zepbound sales beat ...

Xadago is a brand-name oral tablet that’s prescribed for Parkinson’s disease. If you have problems with side effects from Xadago, talk with your doctor or pharmacist. They can discuss ways to ...

Pfizer and Merck & Co have filed their diabetes ... Lilly's Jardiance. The drug was discovered by Pfizer, which sought to link up with Merck because it has the current market leading oral ...

Other factors, including your specific diagnosis, body weight, and medical history, may affect your dosage of ciprofloxacin. Ciprofloxacin is a generic drug that comes as an oral tablet.

Orforglipron, a once-daily glucagon-like peptide-1 (GLP-1) receptor agonist, significantly reduced hemoglobin A1c (HbA1c) in adults with type 2 diabetes (T2D) and inadequate glycemic control with diet ...

American pharmaceutical company Eli Lilly and Company this week announced results from a late-stage clinical trial for its oral diabetes medicine, orforglipron. The once-daily pill, currently ...

An experimental pill may work just as well as injectable, Ozempic-style drugs at treating type 2 diabetes, early trial results suggest. GLP-1 agonists are best known as weight-loss drugs ...

its once-daily oral GLP-1 drug for type 2 diabetes. Warning! GuruFocus has detected 6 Warning Sign with UNH. In its ACHIEVE-1 trial, the drug met its primary goal of reducing A1Ca key diabetes ...

Eli Lilly (NYSE:LLY) shares surged around 14% in premarket trading Thursday after the company reported positive Phase 3 trial results for orforglipron, its once-daily oral GLP-1 drug for type 2 ...

Eli Lil­ly re­port­ed the first Phase 3 da­ta for its oral GLP-1 or­for­glipron Thurs­day morn­ing, say­ing the drug suc­ceed­ed in a type 2 di­a­betes tri­al … ...

Orforglipron cut A1C by 1.2–1.5% and reduced weight up to 15.8 lbs in adults with type 2 diabetes ... Lilly adds that Orforglipron is the first oral small-molecule glucagon-like peptide-1 ...